Skip to main content
NVDA+1.09%AAPL+0.91%MSFT-0.01%GOOGL+2.11%AMZN+1.95%TSM+3.28%SPCX+1.90%AVGO+4.59%TSLA+4.25%META-1.51%LLY+0.15%BRK-B-0.83%MU+3.53%SKHY+2.45%WMT-1.13%AMD+6.02%JPM+0.65%V-0.99%XOM-2.40%JNJ+0.89%ASMLa+2.80%MA-0.59%ABBV-0.02%INTC+4.00%1398.HK+2.15%CVX-1.48%0700.HK-0.31%CSCO+1.15%COST-1.58%ORCL+4.50%KO-1.45%UNH-0.31%PG-0.58%BAC+0.27%1816.HK+1.32%3988.HK+0.66%CAT+3.41%DELL+7.66%HD-0.09%PM+0.72%0857.HK-0.98%AMAT+2.41%AP2d+2.18%0939.HK+0.81%GE+3.33%1288.HK+0.60%LRCX+1.51%NVS+1.91%0005.HK-5.56%MS+2.15%USDJPY+0.67%NZDMXN+0.63%AUDJPY+0.59%EURUSD-0.57%USDMXN+0.53%AUDDKK+0.51%EURZAR-0.50%EURAUD-0.50%EURSEK-0.46%NZDJPY+0.43%GBPUSD-0.42%USDCHF+0.42%GBPTRY+0.41%EURCNH-0.38%GBPZAR-0.37%CADJPY+0.36%EURNZD-0.36%AUDCHF+0.35%GBPAUD-0.34%EURHKD-0.34%USDDKK+0.33%EURSGD-0.32%GBPHKD+0.32%USDCAD+0.32%GBPMXN-0.28%CHFJPY+0.26%EURNOK-0.26%SGDJPY+0.26%AUDNOK+0.25%EURCAD-0.25%GBPJPY+0.23%AUDCAD+0.23%NZDUSD-0.23%CHFSEK-0.22%USDPLN+0.21%NOKJPY+0.20%AUDSGD+0.19%GBPSGD-0.19%GBPNZD-0.19%NZDCHF+0.18%USDTRY+0.17%EURCHF-0.17%USDZAR-0.17%USDILS+0.16%EURGBP-0.15%AUDNZD+0.14%USDSEK-0.13%GBPCAD-0.12%EURPLN-0.11%CADCHF+0.10%EURJPY+0.10%NZDSGD+0.10%CHFSGD-0.08%AUDUSD-0.08%NZDCAD+0.07%USDNOK+0.07%EURCZK-0.05%USDCNH-0.05%PLNJPY+0.05%USDHKD+0.04%USDCOP-0.04%GBPCHF-0.02%CHFNOK-0.02%USDSGD0.00%USDTHB0.00%EURDKK0.00%HG1+1.80%USOIL-1.37%GAUUSD+1.13%XAUUSD+1.13%XAGUSD+0.98%GAGUSD+0.97%XNGUSD+0.96%UKOIL-0.92%XPTUSD+0.66%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+0.98%ETHUSD+23.96%USDTUSD+0.07%XRPUSD+14.74%SOLUSD+17.47%TRXUSDT+0.40%ZECUSDT+6.04%DOGEUSD+20.65%XMRUSDT+1.33%LINKUSD+25.58%BCHUSDT+3.11%XLMUSD+0.75%UNIUSD-0.60%LTCUSD+17.89%SUIUSD+1.41%HBARUSDT-1.02%TONUSD+41.71%TAOUSDT+1.13%AAVEUSD-2.17%DOTUSDT-0.79%ICPUSDT-1.18%ONDOUSDT+0.65%WLDUSDT+1.06%ARBUSDT+0.03%JUPUSDT+1.02%INJUSDT+1.37%ATOMUSDT-1.19%STXUSDT-0.42%TIAUSDT-0.88%PYTHUSDT-2.69%FETUSDT+3.93%SEIUSDT+0.54%IMXUSDT+0.07%GRTUSDT+2.23%OPUSDT-0.20%WIFUSDT-0.06%IOTAUSDT+0.56%POLUSDT+1.01%AXSUSDT+0.83%EOSUSDT+0.92%FARTCOINUSDT+2.66%DYDXUSDT+3.37%GALAUSDT+1.56%ORDIUSDT+2.26%RONINUSDT+1.89%NOTUSDT+1.92%NVDA+1.09%AAPL+0.91%MSFT-0.01%GOOGL+2.11%AMZN+1.95%TSM+3.28%SPCX+1.90%AVGO+4.59%TSLA+4.25%META-1.51%LLY+0.15%BRK-B-0.83%MU+3.53%SKHY+2.45%WMT-1.13%AMD+6.02%JPM+0.65%V-0.99%XOM-2.40%JNJ+0.89%ASMLa+2.80%MA-0.59%ABBV-0.02%INTC+4.00%1398.HK+2.15%CVX-1.48%0700.HK-0.31%CSCO+1.15%COST-1.58%ORCL+4.50%KO-1.45%UNH-0.31%PG-0.58%BAC+0.27%1816.HK+1.32%3988.HK+0.66%CAT+3.41%DELL+7.66%HD-0.09%PM+0.72%0857.HK-0.98%AMAT+2.41%AP2d+2.18%0939.HK+0.81%GE+3.33%1288.HK+0.60%LRCX+1.51%NVS+1.91%0005.HK-5.56%MS+2.15%USDJPY+0.67%NZDMXN+0.63%AUDJPY+0.59%EURUSD-0.57%USDMXN+0.53%AUDDKK+0.51%EURZAR-0.50%EURAUD-0.50%EURSEK-0.46%NZDJPY+0.43%GBPUSD-0.42%USDCHF+0.42%GBPTRY+0.41%EURCNH-0.38%GBPZAR-0.37%CADJPY+0.36%EURNZD-0.36%AUDCHF+0.35%GBPAUD-0.34%EURHKD-0.34%USDDKK+0.33%EURSGD-0.32%GBPHKD+0.32%USDCAD+0.32%GBPMXN-0.28%CHFJPY+0.26%EURNOK-0.26%SGDJPY+0.26%AUDNOK+0.25%EURCAD-0.25%GBPJPY+0.23%AUDCAD+0.23%NZDUSD-0.23%CHFSEK-0.22%USDPLN+0.21%NOKJPY+0.20%AUDSGD+0.19%GBPSGD-0.19%GBPNZD-0.19%NZDCHF+0.18%USDTRY+0.17%EURCHF-0.17%USDZAR-0.17%USDILS+0.16%EURGBP-0.15%AUDNZD+0.14%USDSEK-0.13%GBPCAD-0.12%EURPLN-0.11%CADCHF+0.10%EURJPY+0.10%NZDSGD+0.10%CHFSGD-0.08%AUDUSD-0.08%NZDCAD+0.07%USDNOK+0.07%EURCZK-0.05%USDCNH-0.05%PLNJPY+0.05%USDHKD+0.04%USDCOP-0.04%GBPCHF-0.02%CHFNOK-0.02%USDSGD0.00%USDTHB0.00%EURDKK0.00%HG1+1.80%USOIL-1.37%GAUUSD+1.13%XAUUSD+1.13%XAGUSD+0.98%GAGUSD+0.97%XNGUSD+0.96%UKOIL-0.92%XPTUSD+0.66%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+0.98%ETHUSD+23.96%USDTUSD+0.07%XRPUSD+14.74%SOLUSD+17.47%TRXUSDT+0.40%ZECUSDT+6.04%DOGEUSD+20.65%XMRUSDT+1.33%LINKUSD+25.58%BCHUSDT+3.11%XLMUSD+0.75%UNIUSD-0.60%LTCUSD+17.89%SUIUSD+1.41%HBARUSDT-1.02%TONUSD+41.71%TAOUSDT+1.13%AAVEUSD-2.17%DOTUSDT-0.79%ICPUSDT-1.18%ONDOUSDT+0.65%WLDUSDT+1.06%ARBUSDT+0.03%JUPUSDT+1.02%INJUSDT+1.37%ATOMUSDT-1.19%STXUSDT-0.42%TIAUSDT-0.88%PYTHUSDT-2.69%FETUSDT+3.93%SEIUSDT+0.54%IMXUSDT+0.07%GRTUSDT+2.23%OPUSDT-0.20%WIFUSDT-0.06%IOTAUSDT+0.56%POLUSDT+1.01%AXSUSDT+0.83%EOSUSDT+0.92%FARTCOINUSDT+2.66%DYDXUSDT+3.37%GALAUSDT+1.56%ORDIUSDT+2.26%RONINUSDT+1.89%NOTUSDT+1.92%
BL

Bio-Rad Laboratories, Inc. (BIO)

NYSE • Healthcare

$372.43
+$2.48 (+0.7%)
Market open

Last close at October 26, 2026 at 20:00 UTC

Open$371.8
Previous Close$372.43
Day Range$369.76 - $376
Avg. Volume (3M)230K
Market Cap$10.1B
P/E Ratio44.7
52 Week Range
$236.73$396.23
Next EarningsIn 8 daysNov 4, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$651M100%
Gross Profitminus cost of goods$345.8M53%
Operating Incomeminus R&D and overhead$72.6M11%
Net Incomeminus taxes and the rest$371.4M57%

In plain terms: out of every $100 in revenue, Bio-Rad Laboratories, Inc. keeps $57 as net profit.

Fundamentals & Financials

Revenue (TTM)
$2.5B
Net Income (TTM)
$222.4M
EPS (TTM)
$8.33
ROA (TTM)
2.17%
Current Ratio
3.14
Dividend Yield
0.2%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-2.3%Q1 2026$2.51
-4.1%Q2 2026$1.89
+49.7%Q3 2026$2.62
Next

Nov 4

in 8 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +49.7%

Bio-Rad Laboratories beat expectations on both the top and bottom line in the second fiscal quarter of 2026, reported Aug. 4, with adjusted EPS of $2.62 topping the $1.75 estimate by about +49.7% and revenue of about $651.0 million exceeding the $624.0 million consensus by +4.3%. Revenue slipped 0.1% from $651.6 million a year ago, while adjusted EPS edged up 0.4% from $2.61. Gross profit came to about $345.8 million, leaving gross margin near 53%, and operating income was about $72.6 million with operating margin around 11%. Operating cash flow reached $98.7 million; Bio-Rad also repurchased $31.5 million of stock and paid $15.7 million in dividends. Consensus for the next period calls for EPS of $2.38 on revenue of $651.1 million.

Next report — what to expect

Bio-Rad Laboratories, Inc. (BIO) reports on November 4, 2026. Wall Street expects EPS of $2.23 on revenue of $649.9 million. As trailing context, revenue was -0.1% year over year last quarter. BIO has beaten EPS in 5 of 8 most recent quarters, so focus will be on results versus these expectations.

View full earnings history

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. develops and sells life-science and clinical diagnostics products on the NYSE under BIO, operating in healthcare as a maker of laboratory and diagnostic systems. Across its two businesses, the company generated $2.6 billion of revenue in FY2025.

Name
Bio-Rad Laboratories, Inc.
CEO
Norman D. Schwartz
Website
www.bio-rad.com
Industry
Healthcare
Year Founded
1952
Employees
7,450

Today's Snapshot

AI-generated

BIO is trading 2% higher at 379.84, while its sector was flat. BIO remains within 4.1% of its 52-week high of 396.23.

Trading Volume

Below 10d avg (220.7K)

86.9K

vs S&P 500 Today

Outperforming Market

+1.46%

Updated: October 27, 2026 at 19:26 UTC

Technical Indicators

5 Buy2 Neutral1 Sell
BIO looks neutral as positive price placement and buying volume are balanced by tepid trend strength and mixed momentum. The stock trades comfortably above its major moving averages, supported by positive OBV and a VWAP under the current price, while RSI and CCI show bullish tilt; however, MACD is not yet positive and ADX near 17 indicates a lack of strong trend. Volatility is contained (ATR about 11.6), leaving a constructive but cautious profile. Technical takeaway: Neutral — price is supported but trend strength and momentum are mixed.
All signals
  • EMA (5 indicators)$327.56 - $367.60
    Buy
  • RSI (14)60.56
    Neutral
  • Stochastic %K (14, 3, 3)80.21
    Sell
  • MACD Level (12, 26)-0.38
    Neutral

Peers & Related Assets

TMOThermo Fisher Scientific Inc.
$699.31+2.1%
DHRDanaher Corporation
$232.96+1.1%
RVTYRevvity, Inc.
$160.39+1.0%
TECHBio-Techne Corporation
$72.69+0.2%
RGENRepligen Corporation
$180.17+1.8%
BRKRBruker Corporation
$58.23+1.1%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.